Aakriti (Icardio.AI)
Overview
Aakriti Gupta is a co-founder and the Chief Medical Advisor of iCardio.AI, a pioneering artificial intelligence organization focused on enhancing the interpretation of echocardiographic data through innovative AI solutions. With a robust background in interventional cardiology, Aakriti has significantly contributed to the integration of AI in medical diagnostics, particularly in structural heart disease interventions. Having received training from prestigious institutions like Yale and Columbia, she has an esteemed career that includes co-founding Heartbeat Health, a telehealth startup. Her contributions to cardiology are well-documented in over 80 publications in leading medical journals such as The Lancet and Nature Medicine.
Recent Developments
In the past two years, iCardio.AI, under Aakriti Gupta's guidance, has made significant strides in the field of cardiology through advanced AI technology. Notable recent developments include:
- June 2024: iCardio.AI received FDA 510(k) clearance for its AI-driven EchoMeasure software designed to enhance echocardiographic interpretations. This milestone underscored iCardio.AI's commitment to transforming echocardiography using machine learning (Source: iCardio.AI's website).
- April 2024: The company was granted Breakthrough Device designation from the FDA for its aortic stenosis detection algorithm, a tool designed to operate effectively in both primary care settings and echo labs. This technology promises to bridge critical diagnostic gaps in heart disease (Source: Viz.AI partnership announcement).
- September 2024: iCardio.AI partnered with notable entities like Viz.AI and SARC MedIQ to incorporate its AI solutions for early detection of cardiovascular conditions, specifically through ultrasound technology. This partnership includes significant integration with PACS systems, aimed at improving efficiency and accuracy of medical imaging interpretations (Source: Partnership Announcement).
- October 2023: Joined Cedars-Sinai Accelerator Program, gaining access to crucial clinician and executive support to scale operations and enhance product offerings (Source: HealthTechAlpha).
- September 2023: Collaborated with global healthcare giant Abbott to enhance their cardiac imaging analysis capabilities, particularly focusing on intracardiac echo (ICE) images. This move is expected to expand the reach and application of their AI technologies substantially (Source: Cardiovascular Business).
Personal Information
| Attribute | Information |
|---|---|
| Full Name | Aakriti Gupta |
| Born | Not Publicly Available |
| Nationality | Not Publicly Available |
| Occupation | Doctor, Entrepreneur, Chief Medical Advisor |
| Known For | Co-founder of iCardio.AI & Expertise in Cardiology AI |
| Net Worth | Not Publicly Available |
| Education | Trained at Yale, Columbia, Cedars-Sinai |
Early Life and Education
Although specific details about Aakriti Gupta's early life are not publicly available, it is clear that her educational journey had a significant impact on her career trajectory in cardiology and medical technology. Studying at renowned institutions like Yale and Columbia, Aakriti honed her expertise in structural heart disease interventions, a niche within the cardiology specialty that deals with catheter-based techniques to correct structural defects of the heart. Her exposure to these high-standard academic environments provided her with a foundational understanding of both clinical cardiology and cutting-edge medical research. These formative experiences paved the way for her future endeavors in creating innovative healthcare solutions through artificial intelligence and her participation in high-profile, multidisciplinary research projects.
Career and Notable Achievements
Aakriti Gupta's career in cardiology is highlighted by a blend of clinical excellence and innovative entrepreneurship. Chronologically, her career milestones include:
- Co-founding iCardio.AI, aiming to revolutionize cardiac imaging through AI technologies.
- Leading numerous research initiatives resulting in over 80 scientific publications.
- Steering iCardio.AI's strategic partnerships with industry giants like Abbott and Viz.AI.
- Securing significant FDA recognitions for iCardio.AI's software advancements.
- Pioneering efforts in telehealth through Heartbeat Health, leading a successful Series B funding round.
Current Work and Impact
Currently, Aakriti Gupta holds the position of Chief Medical Advisor at iCardio.AI. Her role involves guiding the clinical integration of AI technologies in cardiology, fostering partnerships that expand the application of such technologies in clinical workflows, and continuously steering advancements in patient care and diagnostic accuracy through AI. Her impact is notably seen in the enhanced capabilities of echocardiographic technologies, aligning with wider health equity goals, such as making advanced diagnostics accessible in diverse healthcare settings. Her contributions have a lasting legacy on the methods cardiologists use to diagnose and treat heart diseases, making a significant global health impact.
Conclusion
Aakriti Gupta has made indelible contributions to cardiology through innovative applications of AI in medical diagnostics. As both an esteemed clinician and visionary entrepreneur, she continues to push boundaries in the integration of technology and healthcare. Her work not only enhances diagnostic procedures but promises a future where healthcare is both efficient and equitable. As iCardio.AI continues to pioneer in the medical tech space, Aakriti's influence will likely remain a critical component in shaping the transformative landscape of healthcare and medical technology.